Institut Català de la Salut
[Giménez-Llort L, Marin-Pardo D] Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Psiquiatria i Medicina Forense, Escola de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Marazuela P, Hernández-Guillamón M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2022-02-25T13:46:12Z
2022-02-25T13:46:12Z
2021-06
Malaltia d'Alzheimer; Envelliment; Supervivència
Alzheimer’s disease; Aging; Survival
Enfermedad de Alzheimer; Envejecimiento; Supervivencia
New evidence refers to a high degree of heterogeneity in normal but also Alzheimer’s disease (AD) clinical and temporal patterns, increased mortality, and the need to find specific end-of-life prognosticators. This heterogeneity is scarcely explored in very old male AD mice models due to their reduced survival. In the present work, using 915 (432 APP23 and 483 C57BL/6 littermates) mice, we confirmed the better survival curves in male than female APP23 mice and respective wildtypes, providing the chance to characterize behavioral signatures in middle-aged, old, and long-lived male animals. The sensitivity of a battery of seven paradigms for comprehensive screening of motor (activity and gait analysis), neuropsychiatric and cognitive symptoms was analyzed using a cohort of 56 animals, composed of 12-, 18- and 24-month-old male APP23 mice and wildtype littermates. Most variables analyzed detected age-related differences. However, variables related to coping with stress, thigmotaxis, frailty, gait, and poor cognition better discriminated the behavioral phenotype of male APP23 mice through the three old ages compared with controls. Most importantly, non-linear age- and genotype-dependent behavioral signatures were found in long-lived animals, suggesting crosstalk between chronological and biological/behavioral ages useful to study underlying mechanisms and distinct compensations through physiological and AD-associated aging.
This work was funded by the BrightFocus Foundation, US (A2017243S). The Neurovascular Research Laboratory is part of the INVICTUS+network, Instituto de Salud Carlos III (ISCIII), Spain [RD16/0019/0021], co-financed by the European Regional Development Fund FEDER. P.M. held a predoctoral fellowship from the Vall d’Hebron Research Institute.
Article
Published version
English
Ratolins; Alzheimer, Malaltia d' - Mortalitat; ORGANISMS::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Eutheria::Rodentia::Muridae::Murinae::Mice; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Dementia::Alzheimer Disease; Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality; ORGANISMOS::Eukaryota::animales::Chordata::vertebrados::mamíferos::Eutheria::Rodentia::Muridae::Murinae::ratones; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::demencia::enfermedad de Alzheimer; Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad
MDPI
Biomedicines;9(6)
https://doi.org/10.3390/biomedicines9060636
info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0019/%2F0021
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]